Route map for the discovery and pre-clinical development of new drugs and treatments for cutaneous leishmaniasis.

Cutaneous leishmaniasis Drug development Drug discovery Formulations Immunomodulatory drugs In vitro assays In vivo models Pharmacokinetics

Journal

International journal for parasitology. Drugs and drug resistance
ISSN: 2211-3207
Titre abrégé: Int J Parasitol Drugs Drug Resist
Pays: Netherlands
ID NLM: 101576715

Informations de publication

Date de publication:
12 2019
Historique:
received: 22 05 2019
revised: 16 06 2019
accepted: 17 06 2019
pubmed: 20 7 2019
medline: 29 4 2020
entrez: 20 7 2019
Statut: ppublish

Résumé

Although there have been significant advances in the treatment of visceral leishmaniasis (VL) and several novel compounds are currently in pre-clinical and clinical development for this manifestation of leishmaniasis, there have been limited advances in drug research and development (R & D) for cutaneous leishmaniasis (CL). Here we review the need for new treatments for CL, describe in vitro and in vivo assays, models and approaches taken over the past decade to establish a pathway for the discovery, and pre-clinical development of new drugs for CL. These recent advances include novel mouse models of infection using bioluminescent Leishmania, the introduction of PK/PD approaches to skin infection, and defined pre-clinical candidate profiles.

Identifiants

pubmed: 31320296
pii: S2211-3207(19)30078-8
doi: 10.1016/j.ijpddr.2019.06.003
pmc: PMC6904839
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

106-117

Subventions

Organisme : Wellcome Trust
ID : 104976
Pays : United Kingdom

Informations de copyright

Copyright © 2019 The Authors. Published by Elsevier Ltd.. All rights reserved.

Références

J Immunol. 2000 Jul 15;165(2):969-77
pubmed: 10878373
Front Cell Infect Microbiol. 2014 May 28;4:67
pubmed: 24904841
Int J Parasitol Drugs Drug Resist. 2019 Dec;11:129-138
pubmed: 30922847
PLoS Negl Trop Dis. 2012;6(11):e1927
pubmed: 23209866
PLoS Negl Trop Dis. 2007 Nov 28;1(2):e34
pubmed: 18060082
Pharm Sci Technolo Today. 2000 Sep 1;3(9):318-326
pubmed: 10996573
Nihon Yakurigaku Zasshi. 2017;149(5):220-224
pubmed: 28484104
Drug Discov Today. 2017 Oct;22(10):1516-1531
pubmed: 28647378
BMC Med. 2017 Apr 7;15(1):76
pubmed: 28385152
Diagn Microbiol Infect Dis. 2013 Mar;75(3):282-91
pubmed: 23312610
Parasitology. 2014 Dec;141(14):1891-7
pubmed: 25111885
Exp Parasitol. 2003 Mar-Apr;103(3-4):160-8
pubmed: 12880593
Am J Trop Med Hyg. 2013 Feb;88(2):216-21
pubmed: 23390221
Trends Parasitol. 2009 Sep;25(9):432-9
pubmed: 19720564
Am J Trop Med Hyg. 2009 Apr;80(4):574-9
pubmed: 19346378
Clin Infect Dis. 2010 Aug 15;51(4):409-19
pubmed: 20624067
J Am Acad Dermatol. 2013 Feb;68(2):284-9
pubmed: 22858005
J Immunother. 2003 Jul-Aug;26(4):313-9
pubmed: 12843793
Int J Parasitol Drugs Drug Resist. 2018 Apr;8(1):81-86
pubmed: 29425734
BMC Public Health. 2018 Mar 15;18(1):358
pubmed: 29544463
Cochrane Database Syst Rev. 2009 Apr 15;(2):CD004834
pubmed: 19370612
Proc Natl Acad Sci U S A. 2008 Jul 22;105(29):10125-30
pubmed: 18626016
Infect Genet Evol. 2014 Dec;28:691-703
pubmed: 25117872
Parasitology. 2008 Mar;135(3):319-26
pubmed: 17961284
Mol Biochem Parasitol. 2000 Oct;110(2):195-206
pubmed: 11071276
Indian J Med Res. 2006 Mar;123(3):399-410
pubmed: 16778319
J Immunol. 2002 Feb 15;168(4):1659-63
pubmed: 11823494
Curr Med Chem. 2008;15(22):2258-64
pubmed: 18781947
Mem Inst Oswaldo Cruz. 2001 Aug;96(6):795-804
pubmed: 11562705
PLoS One. 2011;6(10):e26395
pubmed: 22046280
Clin Infect Dis. 1994 Mar;18(3):381-4
pubmed: 8011819
Exp Parasitol. 2010 Nov;126(3):310-7
pubmed: 20501336
Am J Trop Med Hyg. 2010 Aug;83(2):351-6
pubmed: 20682881
Parasitology. 2013 May;140(6):771-9
pubmed: 23369503
Trans R Soc Trop Med Hyg. 1991 Mar-Apr;85(2):214-6
pubmed: 1909469
Dermatol Ther. 2009 Nov-Dec;22(6):491-502
pubmed: 19889134
Infect Immun. 2014 Dec;82(12):5203-13
pubmed: 25287925
Rev Inst Med Trop Sao Paulo. 2014 Jan-Feb;56(1):1-11
pubmed: 24553602
Parasit Vectors. 2012 Dec 03;5:276
pubmed: 23206339
Clin Infect Dis. 2013 Aug;57(3):370-80
pubmed: 23633111
An Bras Dermatol. 2019 Jan-Feb;94(1):9-16
pubmed: 30726457
N Engl J Med. 2013 Feb 7;368(6):524-32
pubmed: 23388004
Cochrane Database Syst Rev. 2008 Oct 08;(4):CD005067
pubmed: 18843677
Antimicrob Agents Chemother. 2016 May 23;60(6):3524-32
pubmed: 27021313
PLoS Negl Trop Dis. 2009 Jul 28;3(7):e491
pubmed: 19636365
J Antimicrob Chemother. 2010 Mar;65(3):508-11
pubmed: 20089542
J Infect Dis. 1994 Sep;170(3):659-62
pubmed: 8077725
Curr Opin Infect Dis. 2015 Oct;28(5):426-37
pubmed: 26312442
Beilstein J Nanotechnol. 2014 Dec 08;5:2363-73
pubmed: 25551064
PLoS Negl Trop Dis. 2012;6(6):e1671
pubmed: 22720099
PLoS One. 2016 Feb 19;11(2):e0149697
pubmed: 26894430
J Vis Exp. 2012 Apr 21;(62):null
pubmed: 22546739
Adv Drug Deliv Rev. 2001 Mar 1;46(1-3):3-26
pubmed: 11259830
J Microbiol Methods. 2013 May;93(2):95-101
pubmed: 23466934
J Infect Dis. 2018 Feb 14;217(5):840-850
pubmed: 29216363
Parasitol Today. 1995 Jul;11(7):244-7
pubmed: 15275334
Altern Lab Anim. 2008 May;36(2):161-87
pubmed: 18522484
J Exp Med. 1998 Nov 16;188(10):1941-53
pubmed: 9815271
J Infect Dis. 1999 Jun;179(6):1485-94
pubmed: 10228071
Bioanalysis. 2012 May;4(9):1077-95
pubmed: 22612688
Arch Dermatol. 2006 Dec;142(12):1575-9
pubmed: 17178983
Antimicrob Agents Chemother. 2013 Jul;57(7):2913-22
pubmed: 23571538
Clin Infect Dis. 2010 Jan 1;50(1):80-3
pubmed: 19951107
Exp Parasitol. 1987 Dec;64(3):438-47
pubmed: 3678449
Int J Parasitol Drugs Drug Resist. 2017 Aug;7(2):248-249
pubmed: 28623818
PLoS Negl Trop Dis. 2018 Jan 12;12(1):e0006141
pubmed: 29329311
Trans R Soc Trop Med Hyg. 1972;66(4):603-10
pubmed: 5071089
PLoS Negl Trop Dis. 2017 Nov 20;11(11):e0006094
pubmed: 29155816
Acta Trop. 2012 Apr;122(1):36-45
pubmed: 22155571
Nat Biotechnol. 2011 Jul 17;29(8):757-61
pubmed: 21765402
J Med Entomol. 2018 Feb 28;55(2):429-435
pubmed: 29253231
Antimicrob Agents Chemother. 2017 Mar 24;61(4):
pubmed: 28137819
Int J Infect Dis. 2003 Jun;7(2):86-93
pubmed: 12839708
Parasitology. 2018 Apr;145(4):497-507
pubmed: 27974063
PLoS One. 2012;7(5):e35671
pubmed: 22693548
Electron Physician. 2017 Nov 25;9(11):5854-5862
pubmed: 29403630
Infect Immun. 2005 Aug;73(8):4948-54
pubmed: 16041009
J Parasitol. 1999 Apr;85(2):354-9
pubmed: 10219319
PLoS Negl Trop Dis. 2019 Feb 25;13(2):e0007092
pubmed: 30802261
PLoS Negl Trop Dis. 2012;6(7):e1741
pubmed: 22848771
Indian J Med Res. 2011 Jan;133:27-39
pubmed: 21321417
PLoS Negl Trop Dis. 2015 Jul 23;9(7):e0003936
pubmed: 26204525
Clin Vaccine Immunol. 2008 Dec;15(12):1764-70
pubmed: 18945882
Trans R Soc Trop Med Hyg. 2003 Jul-Aug;97(4):469-72
pubmed: 15259484
Antimicrob Agents Chemother. 2018 Apr 26;62(5):
pubmed: 29507073
Proteomics. 2015 Sep;15(18):3169-74
pubmed: 25504905
PLoS Negl Trop Dis. 2015 Mar 31;9(3):e0003666
pubmed: 25826250
PLoS Negl Trop Dis. 2015 Sep 03;9(9):e0003889
pubmed: 26334763
Nat Rev Drug Discov. 2016 Nov;15(11):751-769
pubmed: 27616293
Clin Microbiol Rev. 2018 Aug 29;31(4):
pubmed: 30158301
PLoS Negl Trop Dis. 2017 Jun 8;11(6):e0005480
pubmed: 28594938
PLoS Negl Trop Dis. 2016 May 04;10(5):e0004660
pubmed: 27144739
Cell Immunol. 2016 Nov;309:23-31
pubmed: 27729107
Nat Rev Immunol. 2016 Sep;16(9):581-92
pubmed: 27424773
Front Bioeng Biotechnol. 2018 Nov 06;6:163
pubmed: 30460231
Am J Trop Med Hyg. 2007 Aug;77(2):266-74
pubmed: 17690398
Parasit Vectors. 2016 Mar 11;9:144
pubmed: 26969511
Med Vet Entomol. 2001 Mar;15(1):12-21
pubmed: 11297097
MBio. 2018 Nov 6;9(6):
pubmed: 30401775
PLoS Negl Trop Dis. 2013;7(3):e2130
pubmed: 23556016
Curr Opin Microbiol. 2013 Jun;16(3):303-10
pubmed: 23540353
Exp Parasitol. 2011 Mar;127(3):637-45
pubmed: 21187086
PLoS Negl Trop Dis. 2015 May 29;9(5):e0003820
pubmed: 26024228
J Cutan Pathol. 2012 Apr;39(4):406-12
pubmed: 22443392
J Travel Med. 2014 Mar-Apr;21(2):116-29
pubmed: 24745041
Antimicrob Agents Chemother. 2010 Mar;54(3):984-90
pubmed: 20038619
Antimicrob Agents Chemother. 2009 Sep;53(9):3855-9
pubmed: 19546361
Lancet. 2018 Sep 15;392(10151):951-970
pubmed: 30126638
Antimicrob Agents Chemother. 2018 Sep 24;62(10):
pubmed: 30082295
Expert Rev Anti Infect Ther. 2010 Jul;8(7):739-42
pubmed: 20586558
Kinetoplastid Biol Dis. 2007 Apr 24;6:3
pubmed: 17456237
Expert Opin Drug Deliv. 2014 Apr;11(4):579-97
pubmed: 24620861
Expert Rev Anti Infect Ther. 2018 Jun;16(6):461-469
pubmed: 29889579
PLoS Negl Trop Dis. 2014 May 22;8(5):e2749
pubmed: 24853096
Eur J Pharm Biopharm. 2009 Jun;72(2):324-31
pubmed: 18761087

Auteurs

Diana Caridha (D)

Walter Reed Army Institute for Research, Silver Spring, USA.

Brian Vesely (B)

Walter Reed Army Institute for Research, Silver Spring, USA.

Katrien van Bocxlaer (K)

London School of Hygiene and Tropical Medicine, London, UK; York Biomedical Research Institute, Department of Biology, University of York, York, UK.

Byron Arana (B)

Drugs for Neglected Diseases Initiative (DNDi), Geneva, Switzerland.

Charles E Mowbray (CE)

Drugs for Neglected Diseases Initiative (DNDi), Geneva, Switzerland.

Sima Rafati (S)

Department of Immunotherapy and Leishmania Vaccine Research, Institute Pasteur Institute, Tehran, Iran.

Silvia Uliana (S)

Department of Parasitology, Biomedical Sciences Institute, University of Sao Paulo, Sao Paulo, Brazil.

Rosa Reguera (R)

Department of Biomedical Science, Universidad de Leon, Leon, Spain.

Mara Kreishman-Deitrick (M)

Walter Reed Army Institute for Research, Silver Spring, USA.

Richard Sciotti (R)

Walter Reed Army Institute for Research, Silver Spring, USA.

Pierre Buffet (P)

INTS, Unite Biologie InteÂgreÂe du Globule Rouge, Laboratoire d'Excellence GR-Ex, Paris, France.

Simon L Croft (SL)

London School of Hygiene and Tropical Medicine, London, UK. Electronic address: simon.croft@lshtm.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH